- Oops!Something went wrong.Please try again later.
ASX earnings call for the period ending September 30, 2020.
‘The Encouraging Americans to Save Act’ would give eligible workers a credit to their retirement accounts
At the moment, none seems to be stirring more of a buzz than inflation. Earlier this month, the Bureau of Labor Statistics reported that 12-month inflation, as measured by the Consumer Price Index for All Urban Consumers (CPI-U) was 5.4% in June 2021.
Not only did the banking sector emerge from the pandemic largely unscathed, but the largest banks also endured three stress tests in a 12-month window to prove their durability for capital returns. KeyCorp and Fifth Third are among the names to consider.
What happened The Chinese government strikes the U.S. stock market again. Though today's news of a regulatory crackdown focuses on education companies in China, many U.S.-listed Chinese stocks are being hit this morning.
(Bloomberg) -- Global investors from Tiger Global Management to Temasek Holdings Pte are reeling after China imposed the harshest curbs yet on its $100 billion private tutoring and online education sector.China on Saturday ordered companies that offer tutoring on the school curriculum to go non-profit, potentially wiping out a big chunk of the billions that private equity and venture capital funds have staked on a once red-hot sector.The platforms have lost their ability to go public -- deprivin
It's fair to say that Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are dominating the coronavirus vaccine market these days. Their vaccines have fully immunized 86 million and 62 million Americans, respectively.
Chipmakers Nvidia (NASDAQ: NVDA) and Micron Technology (NASDAQ: MU) have had very different experiences on the stock market so far in 2021, even though both companies have been delivering stellar results quarter after quarter. While Nvidia stock has handily beaten the market, Micron shares have remained nearly flat thus far. Is this a signal that investors should start dumping Micron stock and load up on Nvidia?
Here are three value stocks to buy for the second half of 2021. With such a low valuation relative to its peers, you might think that AbbVie would be struggling. The company's revenue grew 51% year over year in the first quarter of 2021.
Intel (NASDAQ: INTC), the world's largest manufacturer of x86 CPUs for PCs and data centers, is closely scrutinized by tech and financial pundits. Back in 1965, Intel's co-founder Gordon Moore predicted the number of transistors within the same area of silicon would double every year. Using Moore's Law as its foundation, Intel deployed a "tick-tock" cycle for chip upgrades: Each "tick" produced a smaller chip with a higher density, while each "tock" upgraded its architecture but didn't reduce its size.
The dispute adds a juicy new twist to the five-year-old scandal.
Shares of Moderna (NASDAQ: MRNA) jumped 7.8% to a record closing high of $348.83 on Friday after European health officials recommended authorizing the drugmaker's coronavirus vaccine for kids 12 and older. The European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion on Moderna's vaccine. The European Commission will now consider granting authorization for use in adolescents.
Nvidia chips power a future of self-driving cars and cloud gaming, while the global semiconductor market is in a supply crunch. Is Nvidia stock a good buy now?
In the shot, what appears to be a white top can be seen strewn on the floor as Britney Spears covers her bare chest with her hands
Let's talk about the popular Apple Inc. ( NASDAQ:AAPL ). The company's shares led the NASDAQGS gainers with a...
Square (NYSE: SQ) and PayPal (NASDAQ: PYPL) have both generated massive returns for patient investors over the past few years. PayPal, which was spun off from eBay (NASDAQ: EBAY) earlier that year, has advanced more than 720% since its debut to over $300 per share. Square is worth nearly $120 billion as of this writing, while PayPal is worth over $350 billion.
Regulated utilities can hold up relatively well if the economy falters, and some stack up better than others on growth. Duke Energy is one to consider.
Today, let's turn our attention to gene-editing specialist CRISPR Therapeutics (NASDAQ: CRSP). The stock market performance of a clinical-stage biotech like CRISPR Therapeutics is largely tied to the perceived successes (or potential failures) of its pipeline candidates. The company's approach centers on gene editing, which refers to a set of techniques that allow scientists to modify an organism's DNA.
Lucid Motors shares are set to trade on the Nasdaq on Monday after the company's merger with a blank-check company was approved on a second try Friday.
Amazon started the internet-retail revolution. Five other companies, including Sea and Coupang, are taking it further.
Do Ballard Power's recent partnerships threaten Plug Power's dominance in the fuel cell market?